Fly News Breaks for October 18, 2019
ANTM
Oct 18, 2019 | 05:14 EDT
Mizuho analyst Ann Hynes last night initiated coverage of Anthem with a Neutral rating and $262 price target. The analyst thinks Medicaid headwinds could dampen the near-term outlook for Anthem given its exposure to Managed Medicaid. However, she beeves the company's long-term growth could be attractive if it is able to regain the commercial market share lost over the past decade due to uncompetitive pharmacy costs.
News For ANTM From the Last 2 Days
There are no results for your query ANTM